Justin Chun

University of Calgary — Canada

Medicine · Health Sciences

20h-index2.3kcitations54works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(14), Renal and related cancers(9), Chronic Kidney Disease and Diabetes(8), Inflammasome and immune disorders(6), Cellular transport and secretion(5)

Publications54 total

Spatial transcriptomics identifies IL-32 as a lipid droplet-associated cytokine linked to tubular injury in human diabetic kidney disease
Inflammation Research·2026Open Access
Rhomboid protease GlpG regulates type 1 pili quality control and virulence in pathogenic E. coli
Nature Communications·2025· 1 citedOpen Access
Streamlining single-cell spatial transcriptomics for human kidney tissue
BioTechniques·2025Open Access
Mechanistic insight into the regulation of virulence factor type 1 pili in pathogenic <i>E. coli</i> by rhomboid protease GlpG
2025Open Access
Streamlining Spatial Transcriptomics for Human Kidney Tissue
2025Open Access
The spleen tyrosine kinase inhibitor entospletinib resolves inflammation to promote repair following acute kidney injury
JCI Insight·2025· 1 citedOpen Access
CD2AP at the junction of nephropathy and Alzheimer’s disease
Molecular Neurodegeneration·2025· 1 citedOpen Access
Nephron progenitor fate is modulated by angiotensin type 1 receptor signaling in human kidney organoids
Stem Cells·2025· 1 citedOpen Access
IL-32 Is a Lipid Droplet-Associated Mediator of Tubular Injury in Diabetic Kidney Disease
Journal of the American Society of Nephrology·2024
WCN24-638 LUMINAL IMMUNE SURVEILLANCE OF FILTERED ANTIGENS: IMPLICATIONS FOR ADAPTIVE IMMUNE RESPONSES IN THE KIDNEY
Kidney International Reports·2024Open Access
Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data
Current Problems in Cancer·2024· 3 citedOpen Access
3D bioprinting of human iPSC-Derived kidney organoids using a low-cost, high-throughput customizable 3D bioprinting system
Bioprinting·2024· 23 cited
Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs
Journal of Comparative Effectiveness Research·2023· 8 citedOpen Access
Understanding the Current Landscape of Kidney Disease in Canada to Advance Precision Medicine Guided Personalized Care
Canadian Journal of Kidney Health and Disease·2023· 27 citedOpen Access
Comparative Effectiveness of Lenalidomide/Dexamethasone-Based Triplet Regimens for Treatment of Relapsed and/or Refractory Multiple Myeloma in Subgroups Defined By Cytogenetic Risk
Blood·2022· 1 cited
Integration of Exostosin 1 and 2 Into a Clinical Care Pathway for Membranous Nephropathy
Journal of the American Society of Nephrology·2022
Podocyte Maturation in Human Kidney Organoids Is Accelerated With Renin-Angiotensin System Activation
Journal of the American Society of Nephrology·2022
ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit
Proceedings of the National Academy of Sciences·2022· 20 citedOpen Access
P-271: Comparative effectiveness of lenalidomide/ dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States
Clinical Lymphoma Myeloma & Leukemia·2022
Infecting kidney organoids with a cDNA reporter clone of SARS-CoV-2
STAR Protocols·2022· 6 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Hyunjae Chung(17), Daniel A. Muruve(16), Arthur Lau(9), Waleed Rahmani(7), Paul L. Beck(6), Jaye M. Platnich(6), Hallgrímur Benediktsson(6), Martin R. Pollak(6), Graciela Andonegui(6), Akosua Vilaysane(4), Nathan A. Bracey(4), Paul Melançon(4), Balajikarthick Subramanian(4), Seth L. Alper(4), Emily Lauren L. Simms(4), Sarthak Sinha(4), Jeff Biernaskie(4), Maral DerSarkissian(4), Kiril Trpkov(3), Takanori Komada(3)